[HTML][HTML] The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

KE De Visser, JA Joyce - Cancer cell, 2023 - cell.com
Cancers represent complex ecosystems comprising tumor cells and a multitude of non-
cancerous cells, embedded in an altered extracellular matrix. The tumor microenvironment …

Targeting ferroptosis opens new avenues for the development of novel therapeutics

S Sun, J Shen, J Jiang, F Wang, J Min - Signal transduction and …, 2023 - nature.com
Ferroptosis is an iron-dependent form of regulated cell death with distinct characteristics,
including altered iron homeostasis, reduced defense against oxidative stress, and abnormal …

Transformative potential of AI in healthcare: definitions, applications, and navigating the ethical landscape and public perspectives

M Bekbolatova, J Mayer, CW Ong, M Toma - Healthcare, 2024 - mdpi.com
Artificial intelligence (AI) has emerged as a crucial tool in healthcare with the primary aim of
improving patient outcomes and optimizing healthcare delivery. By harnessing machine …

Understanding the complexity of p53 in a new era of tumor suppression

Y Liu, Z Su, O Tavana, W Gu - Cancer cell, 2024 - cell.com
Summary p53 was discovered 45 years ago as an SV40 large T antigen binding protein,
coded by the most frequently mutated TP53 gene in human cancers. As a transcription …

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

X He, X Liu, F Zuo, H Shi, J **g - Seminars in Cancer Biology, 2023 - Elsevier
With biotechnological advancements, innovative omics technologies are constantly
emerging that have enabled researchers to access multi-layer information from the genome …

Harnessing multimodal data integration to advance precision oncology

KM Boehm, P Khosravi, R Vanguri, J Gao… - Nature Reviews …, 2022 - nature.com
Advances in quantitative biomarker development have accelerated new forms of data-driven
insights for patients with cancer. However, most approaches are limited to a single mode of …

Cancer epigenetics: From laboratory studies and clinical trials to precision medicine

X Yu, H Zhao, R Wang, Y Chen, X Ouyang, W Li… - Cell Death …, 2024 - nature.com
Epigenetic dysregulation is a common feature of a myriad of human diseases, particularly
cancer. Defining the epigenetic defects associated with malignant tumors has become a …

Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach

B Zhang, H Shi, H Wang - Journal of multidisciplinary healthcare, 2023 - Taylor & Francis
Cancer is a leading cause of morbidity and mortality worldwide. While progress has been
made in the diagnosis, prognosis, and treatment of cancer patients, individualized and data …

Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective

M Sufyan, Z Shokat, UA Ashfaq - Computers in Biology and Medicine, 2023 - Elsevier
Artificial intelligence (AI) in healthcare plays a pivotal role in combating many fatal diseases,
such as skin, breast, and lung cancer. AI is an advanced form of technology that uses …

PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

S Sinha, R Vegesna, S Mukherjee, AV Kammula… - Nature Cancer, 2024 - nature.com
Tailoring optimal treatment for individual cancer patients remains a significant challenge. To
address this issue, we developed PERCEPTION (PERsonalized Single-Cell Expression …